Coronary bypass surgery for stable angina and unstable angina pectoris

Area of Science:

• Cardiology
• Cardiovascular Surgery

Background:

• Surgical revascularization is superior to medical therapy for angina relief and exercise tolerance.
• Graft atherosclerosis and native vessel disease progression cause angina recurrence 5-10 years post-procedure.
• Recent advancements in myocardial protection and graft patency may improve survival rates.

Purpose of the Study:

• To evaluate the long-term effectiveness of surgical revascularization for coronary artery disease.
• To assess the impact of improved surgical techniques on patient survival.
• To determine the symptomatic benefits of revascularization in patients with unstable angina.
• To advocate for randomized trials comparing angioplasty and surgical revascularization.

Main Methods:

• Review of large randomized trials comparing surgical revascularization and medical therapy.
• Analysis of factors contributing to angina recurrence after bypass surgery.
• Consideration of recent advancements in coronary artery bypass grafting (CABG) techniques.
• Evaluation of outcomes in patients with unstable angina.

Main Results:

• Surgical revascularization provides significant relief from angina and improves exercise capacity.
• A substantial percentage of patients experience angina recurrence within 5-10 years due to graft disease.
• Unstable angina patients have higher operative mortality but experience clear symptomatic benefits from revascularization.
• Improved surgical techniques suggest potential for enhanced survival in a wider patient population.

Conclusions:

• While initially effective, surgical revascularization outcomes can be limited by graft atherosclerosis.
• Advances in surgical techniques may broaden the applicability and improve survival following coronary artery bypass.
• Randomized trials are necessary to compare angioplasty with surgical revascularization for optimal patient management.